Epiplakin1 promotes the progression of esophageal squamous cell carcinoma by activating the PI3K‐AKT signaling pathway

Epiplakin1 promotes the progression of esophageal squamous cell carcinoma by activating the PI3K‐AKT signaling pathway

Abstract Background Epiplakin1 (EPPK1) has been associated with disease progression and unfavorable prognosis of many cancers, but its functional involvement in esophageal squamous cell carcinoma (ESCC) remains to be uncovered. Methods The Quantitative Real‐time PCR (qPCR) assay was employed to dete...

Full description

Bibliographic Details
Main Authors:	Zhongshi Qiao, Chengcheng Dai, Zhiqian Wang, Zifan Wang, Zheng Wang, Tongsong Zhang, Wenjing Niu, Xuezhen Ma
Format:	Article
Language:	English
Published:	Wiley 2022-04-01
Series:	Thoracic Cancer
Subjects:	EPPK1 ESCC PI3K/AKT pathway tumor progression
Online Access:	https://doi.org/10.1111/1759-7714.14366

Similar Items

Loss of miR-204-5p Promotes Tumor Proliferation, Migration, and Invasion Through Targeting YWHAZ/PI3K/AKT Pathway in Esophageal Squamous Cell Carcinoma [Retraction]
by: Shen Z, et al.
Published: (2023-09-01)

PI3K/Akt/mTOR Signaling Pathway: Role in Esophageal Squamous Cell Carcinoma, Regulatory Mechanisms and Opportunities for Targeted Therapy
by: Qian Luo, et al.
Published: (2022-03-01)

PHF5A promotes esophageal squamous cell carcinoma progression via stabilizing VEGFA
by: Zhiwei Chang, et al.
Published: (2024-03-01)

Overexpressed PKMYT1 promotes tumor progression and associates with poor survival in esophageal squamous cell carcinoma
by: Zhang Q, et al.
Published: (2019-08-01)

Pathway-Based Analysis Revealed the Role of Keap1-Nrf2 Pathway and PI3K-Akt Pathway in Chinese Esophageal Squamous Cell Carcinoma Patients With Definitive Chemoradiotherapy
by: Honghai Dai, et al.
Published: (2022-04-01)

FoXA2 promotes esophageal squamous cell carcinoma progression by ZEB2 activation
by: Hanjing Gao, et al.
Published: (2021-09-01)

Raltitrexed enhanced antitumor effect of anlotinib in human esophageal squamous carcinoma cells on proliferation, invasiveness, and apoptosis
by: Hongchao Zhen, et al.
Published: (2023-03-01)

LHX2 Enhances the Malignant Phenotype of Esophageal Squamous Cell Carcinoma by Upregulating the Expression of SERPINE2
by: Xukun Li, et al.
Published: (2022-08-01)

Dandelion Seed Extract Affects Tumor Progression and Enhances the Sensitivity of Cisplatin in Esophageal Squamous Cell Carcinoma
by: Yuxi Li, et al.
Published: (2022-05-01)

Long non-coding RNA KCNQ1 overlapping transcript 1 promotes the progression of esophageal squamous cell carcinoma by adsorbing microRNA-133b
by: Haitao Xu, et al.
Published: (2021-04-01)

Keratin 9 L164P mutation in a Chinese pedigree with epidermolytic palmoplantar keratoderma, cytokeratin analysis, and literature review
by: Xiaoliang Liu, et al.
Published: (2019-11-01)

Post Zygotic, Somatic, Deletion in KERATIN 1 V1 Domain Generates Structural Alteration of the K1/K10 Dimer, Producing a Monolateral Palmar Epidermolytic Nevus
by: Sabrina Caporali, et al.
Published: (2021-06-01)

RETRACTED ARTICLE: Down-regulation of kappa opioid receptor promotes ESCC proliferation, invasion and metastasis via the PDK1-AKT signaling pathway
by: Han-Ming Huang, et al.
Published: (2022-03-01)

A Review: PI3K/AKT/mTOR Signaling Pathway and Its Regulated Eukaryotic Translation Initiation Factors May Be a Potential Therapeutic Target in Esophageal Squamous Cell Carcinoma
by: Ran Huang, et al.
Published: (2022-04-01)

Extracellular Vesicle-Derived miR-105-5p Promotes Malignant Phenotypes of Esophageal Squamous Cell Carcinoma by Targeting SPARCL1 via FAK/AKT Signaling Pathway
by: Binjun He, et al.
Published: (2022-03-01)

PLCD3 promotes malignant cell behaviors in esophageal squamous cell carcinoma via the PI3K/AKT/P21 signaling
by: Mengmeng Wang, et al.
Published: (2023-09-01)

Clinical value of SIRT1 as a prognostic biomarker in esophageal squamous cell carcinoma, a systematic meta-analysis
by: Zhang Yu-ling, et al.
Published: (2022-03-01)

PCDH20 inhibits esophageal squamous cell carcinoma proliferation and migration by suppression of the mitogen-activated protein kinase 9/AKT/β-catenin pathway
by: Yijiao Ning, et al.
Published: (2022-09-01)

ARHGAP20 Expression Inhibited HCC Progression by Regulating the PI3K-AKT Signaling Pathway
by: Liu G, et al.
Published: (2021-04-01)

Isorhamnetin Inhibits Human Gallbladder Cancer Cell Proliferation and Metastasis via PI3K/AKT Signaling Pathway Inactivation
by: Tianyu Zhai, et al.
Published: (2021-02-01)

AURKA knockdown inhibits esophageal squamous cell carcinoma progression through ferroptosis
by: Yuan Mi, et al.
Published: (2024-04-01)

Corrigendum: Isorhamnetin Inhibits Human Gallbladder Cancer Cell Proliferation and Metastasis via PI3K/AKT Signaling Pathway Inactivation
by: Tianyu Zhai, et al.
Published: (2021-10-01)

ID2 Inhibits Bladder Cancer Progression and Metastasis via PI3K/AKT Signaling Pathway
by: Weipu Mao, et al.
Published: (2021-10-01)

Role of PI3K/AKT pathway in squamous cell carcinoma with an especial focus on head and neck cancers
by: Soudeh Ghafouri-Fard, et al.
Published: (2022-08-01)

A prognostic nomogram that includes MPV in esophageal squamous cell carcinoma
by: Qiao He, et al.
Published: (2023-10-01)

Upregulation of IBSP Expression Predicts Poor Prognosis in Patients With Esophageal Squamous Cell Carcinoma
by: Mingyue Wang, et al.
Published: (2019-10-01)

Regulation of ferroptosis by PI3K/Akt signaling pathway: a promising therapeutic axis in cancer
by: Hua Su, et al.
Published: (2024-03-01)

Hypoxic exosomes facilitate angiogenesis and metastasis in esophageal squamous cell carcinoma through altering the phenotype and transcriptome of endothelial cells
by: Yu Mao, et al.
Published: (2019-09-01)

Role of Brg1 in progression of esophageal squamous cell carcinoma
by: Shahram Torkamandi, et al.
Published: (2014-11-01)

Integrative Pathway Analysis of Genes and Metabolites Reveals Metabolism Abnormal Subpathway Regions and Modules in Esophageal Squamous Cell Carcinoma
by: Chunquan Li, et al.
Published: (2017-09-01)

Identifying key mutations of radioresponsive genes in esophageal squamous cell carcinoma
by: Xin Xu, et al.
Published: (2022-09-01)

BRAF-activated non-protein coding RNA (BANCR) advances the development of esophageal squamous cell carcinoma via cell cycle
by: Yang Chunxia, et al.
Published: (2017-04-01)

circ_NRIP1 is oncogenic in malignant development of esophageal squamous cell carcinoma (ESCC) via miR-595/SEMA4D axis and PI3K/AKT pathway
by: Shifan Zhou, et al.
Published: (2021-05-01)

Getting the Akt Together: Guiding Intracellular Akt Activity by PI3K
by: Ivan Yudushkin
Published: (2019-02-01)

Fusobacterium nucleatum predicts a high risk of metastasis for esophageal squamous cell carcinoma
by: Zhen Li, et al.
Published: (2021-10-01)

miR-378d suppresses malignant phenotype of ESCC cells through AKT signaling
by: Jie Peng, et al.
Published: (2021-12-01)

Hinokiflavone Inhibits Growth of Esophageal Squamous Cancer By Inducing Apoptosis via Regulation of the PI3K/AKT/mTOR Signaling Pathway
by: Jida Guo, et al.
Published: (2022-02-01)

Inflammation-related parameter serve as prognostic biomarker in esophageal squamous cell carcinoma
by: Xiaoqin Xu, et al.
Published: (2022-10-01)

INHBA upregulation correlates with poorer prognosis in patients with esophageal squamous cell carcinoma
by: Lyu S, et al.
Published: (2018-06-01)

Integrative analysis of differential genes and identification of a “2‐gene score” associated with survival in esophageal squamous cell carcinoma
by: Lin Wang, et al.
Published: (2019-01-01)